Cargando…

What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?

Detalles Bibliográficos
Autores principales: Sharma, Surendra Kumar, Upadhyay, Vishwanath, Mohan, Alladi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131807/
https://www.ncbi.nlm.nih.gov/pubmed/35345066
http://dx.doi.org/10.4103/ijmr.ijmr_2573_21
_version_ 1784713252366712832
author Sharma, Surendra Kumar
Upadhyay, Vishwanath
Mohan, Alladi
author_facet Sharma, Surendra Kumar
Upadhyay, Vishwanath
Mohan, Alladi
author_sort Sharma, Surendra Kumar
collection PubMed
description
format Online
Article
Text
id pubmed-9131807
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91318072022-05-26 What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? Sharma, Surendra Kumar Upadhyay, Vishwanath Mohan, Alladi Indian J Med Res Editorial Wolters Kluwer - Medknow 2021-09 /pmc/articles/PMC9131807/ /pubmed/35345066 http://dx.doi.org/10.4103/ijmr.ijmr_2573_21 Text en Copyright: © 2021 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Editorial
Sharma, Surendra Kumar
Upadhyay, Vishwanath
Mohan, Alladi
What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
title What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
title_full What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
title_fullStr What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
title_full_unstemmed What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
title_short What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
title_sort what is new in bts 2017 & ats/ers/escmid/idsa 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131807/
https://www.ncbi.nlm.nih.gov/pubmed/35345066
http://dx.doi.org/10.4103/ijmr.ijmr_2573_21
work_keys_str_mv AT sharmasurendrakumar whatisnewinbts2017atsersescmididsa2020guidelinesontreatmentofnontuberculousmycobacterialpulmonarydisease
AT upadhyayvishwanath whatisnewinbts2017atsersescmididsa2020guidelinesontreatmentofnontuberculousmycobacterialpulmonarydisease
AT mohanalladi whatisnewinbts2017atsersescmididsa2020guidelinesontreatmentofnontuberculousmycobacterialpulmonarydisease